FMNB vs TRST

FMNB presents a strong value opportunity, trading significantly below its Graham Number ($20.51) and Intrinsic Value ($17.55). The company maintains a stable financial health profile with a Piotroski F-Score of 4/9 and a healthy ROE of 12.24%, which vastly outperforms the sector average. While earnings growth is modest and recent quarterly surprises have been negative, the low P/E ratio and sustainable 4.88% dividend yield provide a significant margin of safety. The bullish outlook is driven by deep valuation discounts despite a bearish technical trend indicator.

TRST presents a stark contrast between deep fundamental value and deteriorating operational health, highlighted by a weak Piotroski F-Score of 3/9. While the stock is significantly undervalued relative to its Graham Number ($52.77) and Intrinsic Value ($95.88), the low health score and a very bearish technical trend (10/100) suggest significant headwinds. Strong earnings growth (41.7% YoY) and a low PEG ratio (0.63) provide a bullish growth narrative, but these are offset by poor insider sentiment and operational red flags.